RNTX
Rein Therapeutics·NASDAQ
--
--(--)
--
--(--)
2.08 / 10
Underperform
Technical analysis rates RNTX poorly (2.08/10). Bearish candlestick patterns—long lower and upper shadows—dominate, and a MACD death cross signals downward momentum. All three indicators show negative average returns, indicating heightened downside risk.
Analysis Checks(0/3)
Long Lower Shadow
Score1/10
Win Rate39.39%
Hist. Signals99
Avg Return-1.44%
Score1/10
Win Rate39.39%
Hist. Signals99
Avg Return-1.44%
MACD Death Cross
Score2.73/10
Win Rate50.00%
Hist. Signals8
Avg Return-2.49%
Score2.73/10
Win Rate50.00%
Hist. Signals8
Avg Return-2.49%
Long Upper Shadow
Score2.51/10
Win Rate45.68%
Hist. Signals81
Avg Return0.32%
Score2.51/10
Win Rate45.68%
Hist. Signals81
Avg Return0.32%
Long Lower Shadow
Score1/10
Win Rate39.39%
Hist. Signals99
Avg Return-1.44%
Score1/10
Win Rate39.39%
Hist. Signals99
Avg Return-1.44%
Long Upper Shadow
Score2.51/10
Win Rate45.68%
Hist. Signals81
Avg Return0.32%
Score2.51/10
Win Rate45.68%
Hist. Signals81
Avg Return0.32%
MACD Death Cross
Score2.73/10
Win Rate50.00%
Hist. Signals8
Avg Return-2.49%
Score2.73/10
Win Rate50.00%
Hist. Signals8
Avg Return-2.49%
What is the current technical signals for RNTX?
- RNTX presents a Underperform setup with a Technical Score of 2.08/10. Key technical indicators highlight an RSI of 46.06 and a MACD of -0.02, with the trend anchored by the 50-Day SMA at 1.25. Traders should monitor key support at 1.17 and resistance at 1.28.
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
